subject: Stock Updates On Cx, Prot And Amd From Pennytobuck.com [print this page] PROTEONOMIX, INCPROTEONOMIX, INC. (OTCBB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.
Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.
The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (XGen), a Nevis Island limited liability company.
PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomixs operating subsidiary.
CEMEX, S.A.B. de C.V. (NYSE: CX) announced that the company has now been awarded an extension of the initial contract to supply 350,000 cubic meters of ready-mix concrete for the new Hamburg-Moorburg power plant.
The Hamburg-Moorburg plant, located in the southern part of the city, will be one of the most advanced and efficient coal-fired power plants in the world. Starting 2012, it will produce 11 billion kilowatt hours of electricity a year, covering virtually the entire electricity demand of the Hamburg city and providing around 180,000 households with district heating.
Wayss & Freytag Ingenieurbau AG, Northern Division, the company responsible for the construction of the plant, deemed both the quality of the building material and the punctuality of its delivery thoroughly convincing.
CEMEX is a global building materials company that provides high-quality products and reliable service to customers and communities in more than 50 countries throughout the world. CEMEX has a rich history of improving the well-being of those it serves through its efforts to pursue innovative industry solutions and efficiency advancements and to promote a sustainable future. For more information, visit www.cemex.com.
Advanced Micro Devices Inc. (NYSE: AMD) spent $280,000 on lobbying in the latest quarter, $100,000 more than the computer chip maker spent in the same period last year.
AMD lobbied Congress, the Department of Defense, branches of the military and other agencies about general federal funding policies, among other issues. AMD also lobbied on antitrust issues in the semiconductor industry.
AMD is the worlds No. 2 maker of computer microprocessors after Intel Corp.
AMD sued Intel over alleged antitrust violations and complained to regulators around the world about Intels alleged offenses before calling a truce last year. Intel agreed to pay AMD $1.25 billion and the companies struck a new cross-licensing deal.
Advanced Micro Devices (NYSE:AMD) is an innovative technology company dedicated to collaborating with customers and technology partners to ignite the next generation of computing and graphics solutions at work, home and play. For more information, visit http://www.amd.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)
